Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.
Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.
Cell-based therapy approaches: the hope for incurable diseases.
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.
Arterial, venous and other vascular risk factors in multiple sclerosis.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
The role of interleukin-6 signaling in nervous tissue.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.

Pages